MDS-EB

Clinical trials for MDS-EB explained in plain language.

Never miss a new study

Get alerted when new MDS-EB trials appear

Sign up with your email to follow new studies for MDS-EB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Experimental INKmune therapy for blood cancers halted after just 2 patients

Disease control Terminated

This early-stage study tested an experimental drug called INKmune in people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). The goal was to find a safe dose and check for side effects. However, the study was stopped early after only 2 people enrolled, so no c…

Matched conditions: MDS-EB

Phase: PHASE1 • Sponsor: Inmune Bio, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:02 UTC

MDS-EB

Get alerted when new MDS-EB trials appear

Experimental INKmune therapy for blood cancers halted after just 2 patients